Hareesh B Nair

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi BU-32: a novel proteasome inhibitor for breast cancer
    Joseph K Agyin
    Department of Biochemistry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Breast Cancer Res 11:R74. 2009
  2. ncbi Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer
    Hareesh B Nair
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    Biochem Pharmacol 80:1833-43. 2010
  3. ncbi Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation
    Hareesh B Nair
    Department of Gynecology and Obstetrics, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    Cancer Res 65:11164-73. 2005
  4. ncbi Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells
    Rajib Rajhans
    Department of Obstetrics and Gynecology, University of Texas Health Science Center, Floyd Curl Drive, San Antonio, Texas 78229 3900, USA
    Mol Endocrinol 22:649-64. 2008
  5. ncbi HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis
    Rajeshwar Rao Tekmal
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    J Steroid Biochem Mol Biol 106:111-8. 2007
  6. ncbi Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice
    Rajeshwar Rao Tekmal
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, MSC7836, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    J Steroid Biochem Mol Biol 95:9-15. 2005
  7. ncbi Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation
    Nameer Kirma
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 78229, USA
    Cancer Res 64:4162-70. 2004
  8. ncbi Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression
    Nameer Kirma
    Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Cancer Res 67:1918-26. 2007
  9. ncbi Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta
    Ya Guang Liu
    Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Mol Hum Reprod 15:665-73. 2009
  10. ncbi Elevated aromatase expression correlates with cervical carcinoma progression
    Poornachand Veerapaneni
    Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    Gynecol Oncol 114:496-500. 2009

Collaborators

Detail Information

Publications10

  1. ncbi BU-32: a novel proteasome inhibitor for breast cancer
    Joseph K Agyin
    Department of Biochemistry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Breast Cancer Res 11:R74. 2009
    ..This underscores the need to find new and more efficacious proteasome inhibitors. In this study, we evaluate the efficacy of the novel proteasome inhibitor BU-32 (NSC D750499-S) using in vitro and in vivo breast cancer models...
  2. ncbi Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer
    Hareesh B Nair
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    Biochem Pharmacol 80:1833-43. 2010
    ....
  3. ncbi Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation
    Hareesh B Nair
    Department of Gynecology and Obstetrics, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    Cancer Res 65:11164-73. 2005
    ....
  4. ncbi Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells
    Rajib Rajhans
    Department of Obstetrics and Gynecology, University of Texas Health Science Center, Floyd Curl Drive, San Antonio, Texas 78229 3900, USA
    Mol Endocrinol 22:649-64. 2008
    ....
  5. ncbi HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis
    Rajeshwar Rao Tekmal
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    J Steroid Biochem Mol Biol 106:111-8. 2007
    ....
  6. ncbi Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice
    Rajeshwar Rao Tekmal
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, MSC7836, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    J Steroid Biochem Mol Biol 95:9-15. 2005
    ....
  7. ncbi Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation
    Nameer Kirma
    Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, 78229, USA
    Cancer Res 64:4162-70. 2004
    ..These findings, along with the histological data, support the hypothesis that CSF-1 and its receptor are involved in the etiology of breast cancer...
  8. ncbi Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression
    Nameer Kirma
    Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Cancer Res 67:1918-26. 2007
    ..Additionally, our data suggest that transforming growth factor-beta1 may be a factor in inducing the expression of c-fms in cervical cancer cells. The data suggest that c-fms may be a valuable therapeutic target in cervical cancer...
  9. ncbi Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta
    Ya Guang Liu
    Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Mol Hum Reprod 15:665-73. 2009
    ....
  10. ncbi Elevated aromatase expression correlates with cervical carcinoma progression
    Poornachand Veerapaneni
    Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    Gynecol Oncol 114:496-500. 2009
    ..g., IL-6 and TNFalpha) may correlate with aromatase expression...